Company profile
Gold River Productions, Inc.
OTC: GRPS · Healthcare · Drug Manufacturers - Specialty & Generic
#966 of 1,422 Healthcare companies by revenuetop-decile growth
EA Score
——FH —DQ 2GM —SS 46
v0.1 · 25/100 weight · pillars only
↑ listing tenure, revenue growth (YoY) · ↓ disclosure history, filing timeliness
Methodology →Revenue TTM
$16.5k
Rev growth YoY (TTM)
-96.0%
Net income (FY)
-$2.8M
Employees
6
as of 2026-08-27
Market cap
$180.6k
as of 2026-08-27
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$331.6k$331.6k2024
Net income-$2.8M-$2.8M2024
Total assets$948.0k$948.0k2024
Equity-$3.2M-$3.2M2024
Revenue trend
FY2024 – FY2024 · USD
FY24
FY24
FY24
FY24
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Gold River Productions, Inc.’s revenue?
Gold River Productions, Inc. booked $331.6k in FY2024 revenue, growing 227% year over year — faster than 90% of Healthcare companies we track, at a -847.0% net margin.
Peers · Healthcare
Pulse Biosciences, Inc.43DMedX Health Corp29DProvectus Biopharmaceuticals, Inc.35DAllarity Therapeutics, Inc.25DVyome Holdings, Inc.33DInteractive Health Network——Neighbors
Salt Lake →Key facts
CEOAdam Thomas
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
HeadquartersSalt Lake City, UT
ExchangeOTC: GRPS
Employees6
IPO date1994-10-31
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.